{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T12:18:20Z","timestamp":1792671500180,"version":"4.5.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000774","name":"Defense Threat Reduction Agency","doi-asserted-by":"crossref","award":["CBM.VAXBT.03.10.RD.015"],"award-info":[{"award-number":["CBM.VAXBT.03.10.RD.015"]}],"id":[{"id":"10.13039\/100000774","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1016\/j.vaccine.2011.12.010","type":"journal-article","created":{"date-parts":[[2011,12,13]],"date-time":"2011-12-13T17:37:42Z","timestamp":1323797862000},"page":"846-852","source":"Crossref","is-referenced-by-count":20,"title":["Efficacy of a capsule conjugate vaccine against inhalational anthrax in rabbits and monkeys"],"prefix":"10.1016","volume":"30","author":[{"given":"Donald J.","family":"Chabot","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Joyce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Caulfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Cook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Hepler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas J.","family":"Vietri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gordon","family":"Ruthel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wesley","family":"Shoop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise","family":"Pitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Leffel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilson","family":"Ribot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur M.","family":"Friedlander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"17","key":"10.1016\/j.vaccine.2011.12.010_bib0005","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1001\/jama.287.17.2236","article-title":"Anthrax as a biological weapon, 2002: updated recommendations for management","volume":"287","author":"Inglesby","year":"2002","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.vaccine.2011.12.010_bib0010","doi-asserted-by":"crossref","first-page":"933","DOI":"10.3201\/eid0706.010604","article-title":"Bioterrorism-related inhalational anthrax: the first 10 cases reported in the United States","volume":"7","author":"Jernigan","year":"2001","journal-title":"Emerg Infect Dis"},{"issue":"22","key":"10.1016\/j.vaccine.2011.12.010_bib0015","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1001\/jama.282.22.2104","article-title":"Anthrax vaccine: evidence for safety and efficacy against inhalational anthrax","volume":"282","author":"Friedlander","year":"1999","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.vaccine.2011.12.010_bib0020","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1128\/IAI.60.2.662-668.1992","article-title":"Immunization against anthrax with Bacillus anthracis protective antigen combined with adjuvants","volume":"60","author":"Ivins","year":"1992","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2011.12.010_bib0025","series-title":"Vaccines","first-page":"111","article-title":"Anthrax vaccine","author":"Brachman","year":"2008"},{"key":"10.1016\/j.vaccine.2011.12.010_bib0030","series-title":"Current Topics on Microbiology and Immunology","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/978-3-662-05767-4_3","article-title":"Anthrax vaccines","author":"Friedlander","year":"2002"},{"issue":"2","key":"10.1016\/j.vaccine.2011.12.010_bib0035","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1128\/IAI.52.2.509-512.1986","article-title":"Comparative efficacy of Bacillus anthracis live spore vaccine and protective antigen vaccine against anthrax in the guinea pig","volume":"52","author":"Little","year":"1986","journal-title":"Infect Immun"},{"issue":"2","key":"10.1016\/j.vaccine.2011.12.010_bib0040","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1128\/IAI.52.2.356-363.1986","article-title":"Development of antibodies to protective antigen and lethal factor components of anthrax toxin in humans and guinea pigs and their relevance to protective immunity","volume":"52","author":"Turnbull","year":"1986","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2011.12.010_bib0045","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1128\/IAI.70.2.661-664.2002","article-title":"Anthrax spores make an essential contribution to vaccine efficacy","volume":"70","author":"Brossier","year":"2002","journal-title":"Infect Immun"},{"issue":"3","key":"10.1016\/j.vaccine.2011.12.010_bib0050","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/j.1365-2958.1988.tb00041.x","article-title":"Cloning and CO2-dependent expression of the genetic region for encapsulation from Bacillus anthracis","volume":"2","author":"Makino","year":"1988","journal-title":"Mol Microbiol"},{"issue":"2","key":"10.1016\/j.vaccine.2011.12.010_bib0055","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1128\/jb.171.2.722-730.1989","article-title":"Molecular characterization and protein analysis of the cap region, which is essential for encapsulation in Bacillus anthracis","volume":"171","author":"Makino","year":"1989","journal-title":"J Bacteriol"},{"issue":"2","key":"10.1016\/j.vaccine.2011.12.010_bib0060","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1128\/IAI.49.2.291-297.1985","article-title":"Demonstration of a capsule plasmid in Bacillus anthracis","volume":"49","author":"Green","year":"1985","journal-title":"Infect Immun"},{"issue":"2","key":"10.1016\/j.vaccine.2011.12.010_bib0065","first-page":"363","article-title":"Association of the encapsulation of Bacillus anthracis with a 60 megadalton plasmid","volume":"131","author":"Uchida","year":"1985","journal-title":"J Gen Microbiol"},{"issue":"22","key":"10.1016\/j.vaccine.2011.12.010_bib0070","doi-asserted-by":"crossref","first-page":"7765","DOI":"10.1128\/JB.187.22.7765-7772.2005","article-title":"CapE, a 47-amino-acid peptide, is necessary for Bacillus anthracis polyglutamate capsule synthesis","volume":"187","author":"Candela","year":"2005","journal-title":"J Bacteriol"},{"issue":"3","key":"10.1016\/j.vaccine.2011.12.010_bib0075","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/j.1365-2958.1993.tb01710.x","article-title":"Identification of a novel gene, dep, associated with depolymerization of the capsular polymer in Bacillus anthracis","volume":"9","author":"Uchida","year":"1993","journal-title":"Mol Microbiol"},{"issue":"3","key":"10.1016\/j.vaccine.2011.12.010_bib0080","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1111\/j.1365-2958.2005.04718.x","article-title":"Bacillus anthracis CapD, belonging to the gamma-glutamyltranspeptidase family, is required for the covalent anchoring of capsule to peptidoglycan","volume":"57","author":"Candela","year":"2005","journal-title":"Mol Microbiol"},{"issue":"2","key":"10.1016\/j.vaccine.2011.12.010_bib0085","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1111\/j.1365-2958.2008.06533.x","article-title":"Capsule anchoring in Bacillus anthracis occurs by a transpeptidation reaction that is inhibited by capsidin","volume":"71","author":"Richter","year":"2009","journal-title":"Mol Microbiol"},{"issue":"1","key":"10.1016\/j.vaccine.2011.12.010_bib0090","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1128\/AAC.00706-06","article-title":"Poly-gamma-glutamate capsule-degrading enzyme treatment enhances phagocytosis and killing of encapsulated Bacillus anthracis","volume":"51","author":"Scorpio","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.vaccine.2011.12.010_bib0095","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1099\/00221287-34-1-153","article-title":"The roles of serum and carbon dioxide in capsule formation by Bacillus anthracis","volume":"34","author":"Meynell","year":"1964","journal-title":"J Gen Microbiol"},{"issue":"2","key":"10.1016\/j.vaccine.2011.12.010_bib0100","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1046\/j.1365-2672.1999.00887.x","article-title":"Control of virulence gene expression in Bacillus anthracis","volume":"87","author":"Hoffmaster","year":"1999","journal-title":"J Appl Microbiol"},{"issue":"6","key":"10.1016\/j.vaccine.2011.12.010_bib0105","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1046\/j.1365-2958.1997.3041667.x","article-title":"Cross-talk to the genes for Bacillus anthracis capsule synthesis by atxA, the gene encoding the trans-activator of anthrax toxin synthesis","volume":"23","author":"Uchida","year":"1997","journal-title":"Mol Microbiol"},{"issue":"2","key":"10.1016\/j.vaccine.2011.12.010_bib0110","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1128\/JB.186.2.307-315.2004","article-title":"AtxA controls Bacillus anthracis capsule synthesis via acpA and a newly discovered regulator, acpB","volume":"186","author":"Drysdale","year":"2004","journal-title":"J Bacteriol"},{"issue":"3","key":"10.1016\/j.vaccine.2011.12.010_bib0115","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1042\/bj0630437","article-title":"Polyglutamic acid from Bacillus anthracis grown in vivo; structure and aggressin activity","volume":"63","author":"Zwartouw","year":"1956","journal-title":"Biochem J"},{"issue":"1","key":"10.1016\/j.vaccine.2011.12.010_bib0120","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.vaccine.2004.05.029","article-title":"Anthrax capsule vaccine protects against experimental infection","volume":"23","author":"Chabot","year":"2004","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.vaccine.2011.12.010_bib0125","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/0264-410X(94)90223-2","article-title":"Human live anthrax vaccine in the former USSR","volume":"12","author":"Shlyakhov","year":"1994","journal-title":"Vaccine"},{"issue":"9","key":"10.1016\/j.vaccine.2011.12.010_bib0130","doi-asserted-by":"crossref","first-page":"5460","DOI":"10.1128\/IAI.72.9.5460-5463.2004","article-title":"The capsule of Bacillus anthracis behaves as a thymus-independent type 2 antigen","volume":"72","author":"Wang","year":"2004","journal-title":"Infect Immun"},{"issue":"15","key":"10.1016\/j.vaccine.2011.12.010_bib0135","doi-asserted-by":"crossref","first-page":"8945","DOI":"10.1073\/pnas.1633512100","article-title":"Poly(gamma-d-glutamic acid) protein conjugates induce IgG antibodies in mice to the capsule of Bacillus anthracis: a potential addition to the anthrax vaccine","volume":"100","author":"Schneerson","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"10.1016\/j.vaccine.2011.12.010_bib0140","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0928-8244(03)00366-3","article-title":"Induction of opsonic antibodies to the gamma-d-glutamic acid capsule of Bacillus anthracis by immunization with a synthetic peptide-carrier protein conjugate","volume":"40","author":"Wang","year":"2004","journal-title":"FEMS Immunol Med Microbiol"},{"issue":"6","key":"10.1016\/j.vaccine.2011.12.010_bib0145","first-page":"577","article-title":"Studies on the relation of a prior immune response to immunogenicity","volume":"13","author":"Goodman","year":"1967","journal-title":"Immunology"},{"issue":"2","key":"10.1016\/j.vaccine.2011.12.010_bib0150","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/j.1574-695X.2009.00595.x","article-title":"Poly-gamma-d-glutamic acid and protective antigen conjugate vaccines induce functional antibodies against the protective antigen and capsule of Bacillus anthracis in guinea-pigs and rabbits","volume":"57","author":"Lee","year":"2009","journal-title":"FEMS Immunol Med Microbiol"},{"issue":"19","key":"10.1016\/j.vaccine.2011.12.010_bib0155","doi-asserted-by":"crossref","first-page":"10925","DOI":"10.1073\/pnas.1834478100","article-title":"Wang JY A dually active anthrax vaccine that confers protection against both bacilli and toxins","volume":"100","author":"Rhie","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"issue":"8","key":"10.1016\/j.vaccine.2011.12.010_bib0160","doi-asserted-by":"crossref","first-page":"4831","DOI":"10.1074\/jbc.M509432200","article-title":"Immunogenicity and protective efficacy of Bacillus anthracis poly-gamma-d-glutamic acid capsule covalently coupled to a protein carrier using a novel triazine-based conjugation strategy","volume":"281","author":"Joyce","year":"2006","journal-title":"J Biol Chem"},{"issue":"14","key":"10.1016\/j.vaccine.2011.12.010_bib0165","doi-asserted-by":"crossref","first-page":"5042","DOI":"10.1073\/pnas.0401351101","article-title":"mAbs to Bacillus anthracis capsular antigen for immunoprotection in anthrax and detection of antigenemia","volume":"101","author":"Kozel","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"10.1016\/j.vaccine.2011.12.010_bib0170","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1128\/IAI.01133-06","article-title":"Protective and immunochemical activities of monoclonal antibodies reactive with the Bacillus anthracis polypeptide capsule","volume":"75","author":"Kozel","year":"2007","journal-title":"Infect Immun"},{"issue":"1","key":"10.1016\/j.vaccine.2011.12.010_bib0175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1139\/cjm-45-1-1","article-title":"Isolation of an asporogenic (spoOA) protective antigen-producing strain of Bacillus anthracis","volume":"45","author":"Worsham","year":"1999","journal-title":"Can J Microbiol"},{"issue":"2","key":"10.1016\/j.vaccine.2011.12.010_bib0180","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/0022-1759(84)90288-6","article-title":"A computer program for the evaluation of ELISA data obtained using an automated microtiter plate absorbance reader","volume":"74","author":"Caulfield","year":"1984","journal-title":"J Immunol Methods"},{"issue":"32","key":"10.1016\/j.vaccine.2011.12.010_bib0185","doi-asserted-by":"crossref","first-page":"4768","DOI":"10.1016\/S0264-410X(01)00234-1","article-title":"In vitro correlate of immunity in a rabbit model of inhalational anthrax","volume":"19","author":"Pitt","year":"2001","journal-title":"Vaccine"},{"issue":"11\u201312","key":"10.1016\/j.vaccine.2011.12.010_bib0190","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/S0264-410X(98)80112-6","article-title":"Comparative efficacy of experimental anthrax vaccine candidates against inhalation anthrax in rhesus macaques","volume":"16","author":"Ivins","year":"1998","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.12.010_bib0195","series-title":"Guide for the Care and Use of laboratory Animals","author":"National Research Council","year":"1996"},{"key":"10.1016\/j.vaccine.2011.12.010_bib0200","unstructured":"Pasteur L (with the collaboration of Mr. Chamberland and Mr. Roux). Summary report of the experiments conducted at Pouilly-le-Fort, near Melun, on the anthrax vaccination (French). Comptes Rendus de l\u2019Academie des Science 1881; 92:1378\u201383."},{"issue":"3","key":"10.1016\/j.vaccine.2011.12.010_bib0205","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1017\/S0022172400063488","article-title":"Anthrax. William Smith Greenfield, M.D., F.R.C.P., Professor Superintendent, the Brown Animal Sanatory Institution (1878\u201381). Concerning the priority due to him for the production of the first vaccine against anthrax","volume":"85","author":"Tigertt","year":"1980","journal-title":"J Hyg (Lond)"},{"key":"10.1016\/j.vaccine.2011.12.010_bib0210","first-page":"303","article-title":"Method for vaccinating sheep and young dogs (French)","volume":"91","author":"Toussaint","year":"1880","journal-title":"C R Hebd Seances Acad Sci"},{"issue":"1-3","key":"10.1016\/j.vaccine.2011.12.010_bib0215","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0168-1656(95)00092-5","article-title":"Development of novel vaccines against anthrax in man","volume":"44","author":"Stepanov","year":"1996","journal-title":"J Biotechnol"},{"key":"10.1016\/j.vaccine.2011.12.010_bib0220","series-title":"The anthrax vaccine: Is it safe? Does it work?","year":"2002"},{"issue":"33\u201334","key":"10.1016\/j.vaccine.2011.12.010_bib0225","doi-asserted-by":"crossref","first-page":"5950","DOI":"10.1016\/j.vaccine.2006.05.044","article-title":"Immunogenicity and tolerance of ascending doses of a recombinant protective antigen (rPA102) anthrax vaccine: a randomized, double-blinded, controlled, multicenter trial","volume":"24","author":"Gorse","year":"2006","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2011.12.010_bib0230","doi-asserted-by":"crossref","first-page":"205","DOI":"10.4161\/hv.3.5.4459","article-title":"Safety, reactogenicity and immunogenicity of a recombinant protective antigen anthrax vaccine given to healthy adults","volume":"3","author":"Campbell","year":"2007","journal-title":"Hum Vaccine"},{"issue":"17\u201318","key":"10.1016\/j.vaccine.2011.12.010_bib0235","first-page":"1846","article-title":"Expression of cereolysine AB genes in Bacillus anthracis vaccine strain ensures protection against experimental hemolytic anthrax infection","volume":"15","author":"Pomerantsev","year":"2007","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2011.12.010_bib0240","doi-asserted-by":"crossref","DOI":"10.3201\/eid1404.070969","article-title":"Conference report on public health and clinical guidelines for anthrax","volume":"14","author":"Stern","year":"2008","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2011.12.010_bib0245","first-page":"982","article-title":"The pathology of experimental anthrax in rabbits exposed by inhalation and subcutaneous inoculation","volume":"122","author":"Zaucha","year":"1998","journal-title":"Arch Pathol Lab Med"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11019335?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11019335?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,28]],"date-time":"2020-06-28T15:41:54Z","timestamp":1593358914000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X11019335"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1]]},"references-count":49,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["S0264410X11019335"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2011.12.010","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,1]]}}}